Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Cancer and CCL22, with related work in Chemotherapy, Helicobacter pylori, Parenteral nutrition. Notable publications include 'Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)', 'C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical...', and 'Interleukin ( IL ) -4 -590C > T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysis'.
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)
C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy
Interleukin ( IL ) -4 -590C > T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysis
[Details of enteral nutrition for gastric carcinoma patients].
PubMed 2013cited by 0position: first
[A case-control study on the risk factors of gastric cancer in Heilongjiang province].
PubMed 2012cited by 0position: middle